Drug dramatically reduces kids’ life-threatening reactions to food allergen traces
An injectable drug used for decades to treat asthma substantially reduced potentially life-threatening reactions in children with an allergy who were exposed to trace amounts of peanuts, eggs, milk and cashew, according to new research. The Food and Drug Administration earlier this month approved omalizumab, marketed as Xolair, to treat severe food allergies in certain … Read more
